Page 1 od 25 rezultati
FIELD OF THE INVENTION
The present invention is related to a method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale.
BACKGROUND OF THE INVENTION
Chinese crude drugs or spices eg. Zingiber officinale, Eugenia caryophyllata, Allium sativum,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to a vascular implant and, more specifically, to a multiple drug-eluting intravascular implant and methods of using the implant to perform percutaneous transluminal coronary angioplasty and intracerebral vessel
The present invention relates to the use of amtolmetin guacyl for the production of an anti-inflammatory drug for intestinal inflammations. In the present description amtolmetin guacyl, whose chemical name is 2-metoxyphenyl-1-methyl-5-p-methylbenzoyl-pirrol-2-acetamido acetate, will be also referred
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
The invention relates to novel chemical compounds having immunomodulatory activity and/or anti-restenotic activity and
FIELD OF THE INVENTION
This invention relates to medical and nutritional uses of extracts and products containing cocoa polyphenols including cocoa procyanidins.
BACKGROUND OF THE INVENTION
Polyphenols are an incredibly diverse group of compounds (Ferriera et al., `Diversity of Structure and
FIELD OF THE INVENTION
The present invention relates to methods and apparatus for treating damaged or diseased cardiovascular structures. More particularly, the present invention relates to cardiovascular prostheses for treating and/or reconstructing damaged or diseased cardiovascular
FIELD OF INVENTION
The present invention relates in general to acetylsalicylic acid salts, and in particular to a new and useful water soluble acetylsalicylic acid salts and the method of making the same. Acetylsalicylic acid is a most widely used drug, known chiefly for its analgesic properties.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
Embodiments of the invention relate to novel chemical compounds having immunomodulatory activity and/or anti-restenotic
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
The invention relates to novel chemical compounds having immunomodulatory activity and/or anti-restenotic activity and
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
Embodiments of the invention relate to novel chemical compounds having immunomodulatory activity and/or anti-restenotic
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
Embodiments of the invention relate to novel chemical compounds having immunomodulatory activity and/or anti-restenotic
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
Embodiments of the invention relate to novel chemical compounds having immunomodulatory activity and/or anti-restenotic
BACKGROUND OF THE INVENTION
Field of the Invention
The invention relates to the use of a drug delivery device with openings to deliver a plurality of beneficial agents to bodily lumens. In particular, the invention relates to the delivery of different beneficial agents, different quantities of
FIELD OF THE INVENTION
This invention relates to the field of antiinflammatory drugs and compositions that prevent reduce or reverse the gastrointestinal, renal and other toxicities associated with antiinflammatory agents, and at the same time provide additional tissue protection.
STATEMENT
FIELD OF THE INVENTION
The present invention describes novel nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) inhibitors and novel compositions comprising at least one nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) inhibitor, and, optionally, at least one compound that donates,